Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter …
…, R Juarez, V Murthy, C Lawhn-Heath… - JAMA …, 2021 - jamanetwork.com
Importance The presence of pelvic nodal metastases at radical prostatectomy is associated
with biochemical recurrence after prostatectomy. Objective To assess the accuracy of …
with biochemical recurrence after prostatectomy. Objective To assess the accuracy of …
Impact of 68Ga-PSMA-11 PET on the management of recurrent prostate cancer in a prospective single-arm clinical trial
…, SC Behr, IWK Wu, C Lawhn-Heath… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) ligand PET induces management changes in
patients with prostate cancer. We aim to better characterize the impact of 68 Ga-PSMA-11 …
patients with prostate cancer. We aim to better characterize the impact of 68 Ga-PSMA-11 …
[PDF][PDF] SNMMI procedure standard/EANM practice guideline for SSTR PET: imaging neuroendocrine tumors
Somatostatin receptor (SSTR) imaging using PET has replaced scintigraphic imaging using
111In-pentetreotide (OctreoScan), unless PET is unavailable. Several benefits of SSTR PET …
111In-pentetreotide (OctreoScan), unless PET is unavailable. Several benefits of SSTR PET …
Prostate-specific membrane antigen PET in prostate cancer
C Lawhn-Heath, A Salavati, SC Behr, SP Rowe… - Radiology, 2021 - pubs.rsna.org
Prostate-specific membrane antigen (PSMA)–targeted radiopharmaceuticals are playing a
large role at the time of initial staging and biochemical recurrence for localizing prostate …
large role at the time of initial staging and biochemical recurrence for localizing prostate …
Utility of head CT in the evaluation of vertigo/dizziness in the emergency department
C Lawhn-Heath, C Buckle, G Christoforidis… - Emergency …, 2013 - Springer
Acute dizziness (including vertigo) is a common reason to visit the emergency room, and
imaging with head CT is often performed initially to exclude a central cause. In this study, …
imaging with head CT is often performed initially to exclude a central cause. In this study, …
[HTML][HTML] False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial
…, R Slavik, PR Carroll, C Lawhn-Heath… - European journal of …, 2021 - Springer
Purpose Readers need to be informed about potential pitfalls of [ 68 Ga]Ga-PSMA-11 PET
interpretation. Methods Here we report [ 68 Ga]Ga-PSMA-11 PET findings discordant with the …
interpretation. Methods Here we report [ 68 Ga]Ga-PSMA-11 PET findings discordant with the …
[HTML][HTML] Gallium-68 prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study
C Lawhn-Heath, SS Yom, C Liu, JE Villanueva-Meyer… - EJNMMI research, 2020 - Springer
Background Prostate-specific membrane antigen (PSMA) is expressed in the microvasculature
of thyroid cancer. This suggests the potential use of PSMA as a diagnostic agent in …
of thyroid cancer. This suggests the potential use of PSMA as a diagnostic agent in …
Imaging prostate cancer with prostate-specific membrane antigen PET/CT and PET/MRI: current and future applications
…, WP Fendler, C Lawhn-Heath… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to describe the large number of radiotracers
being evaluated for prostate-specific membrane antigen (PSMA) PET, which is becoming a …
being evaluated for prostate-specific membrane antigen (PSMA) PET, which is becoming a …
Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose
C Lawhn-Heath, TA Hope, J Martinez, EK Fung… - The lancet …, 2022 - thelancet.com
Radionuclide therapy is a rapidly expanding oncological treatment method. Overwhelmingly,
the application of radionuclide therapy in clinical practice relies on fixed or empirical …
the application of radionuclide therapy in clinical practice relies on fixed or empirical …
Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS)
H Cho, NS Mundada, LG Apostolova… - Alzheimer's & …, 2023 - Wiley Online Library
INTRODUCTION We aimed to describe baseline amyloid‐beta (Aβ) and tau‐positron emission
tomograrphy (PET) from Longitudinal Early‐onset Alzheimer's Disease Study (LEADS), a …
tomograrphy (PET) from Longitudinal Early‐onset Alzheimer's Disease Study (LEADS), a …